Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Prednisolone/ciclosporin

Next Previous
Search
Drug Profile

Prednisolone/ciclosporin

Alternative Names: FOV 1101; FOV1101-00; Prednisolone/cyclosporine A; Prednisporin

Latest Information Update: 05 Nov 2023

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator CombinatoRx; Fovea Pharmaceuticals
  • Developer Sanofi
  • Class Ciclosporins; Glucocorticoids; Pregnadienetriols
  • Mechanism of Action Calcineurin inhibitors; Glucocorticoid receptor agonists; Immunosuppressants; P-glycoprotein inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Discontinued Allergic conjunctivitis

Most Recent Events

  • 25 Jul 2016 EPIRUS Biopharmaceuticals files for Chapter 7 bankruptcy (Epirus Biopharmaceuticals 8-K, July 2016)
  • 17 Jul 2014 Discontinued - Phase-II for Allergic conjunctivitis in USA (Topical)
  • 15 Jul 2014 Zalicus has merged with EPIRUS Biopharmaceuticals

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top